Japanese and Chinese stocks drop more than 1% ...

Shares in European arms makers rose on Thursday to a fresh record high after President Donald Trump called for higher U.S. defence spending. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

PRESS RELEASE January 7th, 2026 RCI BANQUE: ISSUANCE OF EUR 900 MILLION FIXED RATE NOTES MATURING IN FEBRUARY 2032 RCI Banque, operating under the commercial brand Mobilize Financial Services, announces the issuance of a € 900m 6-year and 1-month bond (Feb-32) bearing a 3.75% coupon. The deal attracted a final order book around 5.5 billion euro coming from more than 200 investors. Contact Analysts and InvestorsFinancial communication+ 33(0) 1 76 88 81 74contact_investor@rcibanque.com About Mobilize F ...

Semiconductor wafer maker Soitec has appointed Laurent Remont as its new chief executive officer, to replace Pierre Barnabe from April, the French company said on Thursday. ...

It is no secret now, gold has been in a bull market for almost two years now, and gold miners are in a catch-up rally since early 2025. The gold miners have mostly underperformed the commodity, butI am always on the lookout for GARP (Growth At a Reasonable Price) and turnaround stocks, in the dirt and under the rocks. Valuation matters and is the foundation of my stock picking strategy. Following me will allow you to read about stocks with limited downside and unlimited upside.My name is Akim and I am a pro ...

Rivian Automotive is recalling 19,641 previously serviced R1S and R1T electric vehicles in the U.S., citing incorrectly assembled rear toe link, the U.S. National Highway Traffic Safety Administration... ...

The supermarket chain said like-for-like group sales excluding fuel increased 2.9% on year for the 19 weeks ending Jan. 3. ...

Shares of Revolution Medicines Inc. (NASDAQ:RVMD) tumbled in after-hours trading on Wednesday after AbbVie Inc. (NYSE:ABBV) denied reports that it was in talks to acquire the cancer-drug developer, reversing an over 28% rally sparked by the takeover speculation.Report Lifts AbbVie Stock Too As Investors Cheer Oncology ProspectsThe Wall Street Journal reported on Wednesday that AbbVie was in advanced talks to buy Revolution Medicines, but the terms and a potential purchase price were not disclosed. Revolutio ...

核心观点 - 2026年1月7日 法院的认证决定为法国巴黎银行就2025年10月的陪审团裁决提起上诉扫清了道路 公司对此表示欢迎并将按计划推进上诉程序 [2] - 公司认为十月裁决在事实和法律上存在根本缺陷 并将在上诉中论证审判所适用的法律标准是基于对相关瑞士法律的错误应用 且对事实的全面公正审查应导致案件被驳回 [3] - 公司强调十月裁决仅针对三名原告 不应具有更广泛的适用性 任何 extrapolation 或 speculation 都是错误的 [3] - 公司已为上诉做好充分准备 并相信其论点将说服上诉法院推翻十月裁决 [4] 法律程序进展 - 2026年1月7日 法官认证了2025年10月的裁决 这一程序性步骤为公司提起上诉铺平了道路 [2] - 公司计划推进上诉程序 旨在推翻十月裁决 [2][4] 公司立场与论证 - 公司认为十月陪审团裁决在事实和法律层面均存在根本性缺陷 [3] - 公司上诉的核心论点是 审判中适用的法律标准错误地应用了相关的瑞士法律 [3] - 公司主张对案件事实进行完整且公正的审查后 应驳回该案 [3] - 公司明确指出十月裁决仅对案件中的三位原告具有特定性 不应被引申或推而广之 [3] 公司准备与预期 - 公司表示已为上诉做好全面准备 [4] - 公司对其上诉论点充满信心 并预计十月裁决将在上诉中被推翻 [4]